Sebelius nomination clears Finance
This article was originally published in The Gray Sheet
Executive Summary
Kansas Gov. Kathleen Sebelius' nomination to become the next Secretary of Health and Human Services is scheduled to be voted on by the full Senate April 28 after clearing the Senate Finance Committee in a 15-4 vote April 21. Prior to the committee vote, Sen. Jon Kyl, R-Ariz., said he cannot support the nomination due to "contradictory statements" Sebelius has made on comparative effectiveness research. Sebelius' statements about comparative effectiveness "left me with no assurance that HHS federal health care programs or any new entity such as the Coordinating Council will not use comparative effectiveness research as a tool to deny care," Kyl said ("1The Gray Sheet" April 6, 2009, p. 3). He and three other committee Republicans opposed the nomination while approving Democrat members were joined by Republican Sens. Olympia Snowe of Maine and Pat Roberts of Kansas
You may also be interested in...
NIH Dives Into Comparative Effectiveness Clash With Grant Opportunities
A 181-page grant application 1request from the National Institutes of Health has struck a nerve among congressional lawmakers debating the particulars of comparative-effectiveness research and comprehensive health reform
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.